Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
Leuk Res. 2010 Jul;34(7):831-6. doi: 10.1016/j.leukres.2010.01.001. Epub 2010 Jan 21.
The fms-like tyrosine kinase 3 (FLT3) gene aberrations, internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, are frequent in acute promyelocytic leukemia (APL). To evaluate their prognostic significance, we performed a systematic review and meta-analysis. Eleven studies covering a total of 1063 subjects were included in this review. Incidence of ITD and TKD mutations was 12-38% and 2-20%, respectively. In 9 of 11 studies, ITD was associated with high WBC count at the time of diagnosis, which is a known prognostic indicator in APL. Patients with ITD had inferior 3-year overall survival compared to patients without ITD (risk ratio 1.42, 95% CI: 1.04-1.95). Similarly, ITD was also associated with adverse 3-year disease-free survival (risk ratio 1.48, 95% CI: 1.02-2.15). There were only two studies that evaluated the association of TKD mutation in APL; both showed a trend towards worse survival in patients with mutated TKD. In conclusion, FLT3 ITD is associated with high WBC at diagnosis in patients with APL. Although the available literature is limited to observational studies, our systematic review suggests that FLT3 mutations, especially ITD, can adversely affect overall survival and disease-free survival in APL.
Fms 样酪氨酸激酶 3(FLT3)基因异常,包括内部串联重复(ITD)和酪氨酸激酶结构域(TKD)突变,在急性早幼粒细胞白血病(APL)中很常见。为了评估其预后意义,我们进行了系统评价和荟萃分析。本综述共纳入了 11 项研究,总计 1063 例患者。ITD 和 TKD 突变的发生率分别为 12%-38%和 2%-20%。在 11 项研究中的 9 项研究中,ITD 与诊断时高白细胞计数相关,这是 APL 中的一个已知预后指标。与无 ITD 的患者相比,有 ITD 的患者 3 年总生存率较低(风险比 1.42,95%CI:1.04-1.95)。同样,ITD 也与不良的 3 年无病生存率相关(风险比 1.48,95%CI:1.02-2.15)。仅有两项研究评估了 TKD 突变在 APL 中的相关性,均显示 TKD 突变患者的生存情况较差。总之,FLT3 ITD 与 APL 患者诊断时的高白细胞计数相关。尽管现有文献仅限于观察性研究,但我们的系统评价表明,FLT3 突变,特别是 ITD,可能会对 APL 的总生存率和无病生存率产生不利影响。